{"id":"https://openalex.org/W1501976972","doi":"https://doi.org/10.4049/jimmunol.138.11.4023","title":"Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.","display_name":"Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.","publication_year":1987,"publication_date":"1987-06-01","ids":{"openalex":"https://openalex.org/W1501976972","doi":"https://doi.org/10.4049/jimmunol.138.11.4023","mag":"1501976972","pmid":"https://pubmed.ncbi.nlm.nih.gov/3295044"},"language":"en","primary_location":{"id":"doi:10.4049/jimmunol.138.11.4023","doi":"https://doi.org/10.4049/jimmunol.138.11.4023","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.138.11.4023","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000260833","display_name":"Michael A. Palladino","orcid":"https://orcid.org/0000-0002-4687-7612","observed_orcids":["https://orcid.org/0000-0002-4687-7612"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M A Palladino","raw_affiliation_strings":["Department of Molecular Immunology, Genentech, Inc. , South San Francisco, CA 94080","GENENTECH,INC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Immunology, Genentech, Inc. , South San Francisco, CA 94080","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"GENENTECH,INC","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111977134","display_name":"M. Refaat Shalaby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M R Shalaby","raw_affiliation_strings":["Department of Pharmacological Sciences, Genentech, Inc. , South San Francisco, CA 94080","GENENTECH,INC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacological Sciences, Genentech, Inc. , South San Francisco, CA 94080","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"GENENTECH,INC","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018871983","display_name":"Susan Mukavitz Kramer","orcid":"https://orcid.org/0000-0002-8936-8607","observed_orcids":["https://orcid.org/0000-0002-8936-8607"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S M Kramer","raw_affiliation_strings":["Assay Development, Genentech, Inc. , South San Francisco, CA 94080","GENENTECH,INC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Assay Development, Genentech, Inc. , South San Francisco, CA 94080","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"GENENTECH,INC","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051927385","display_name":"Bobbe L. Ferraiolo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B L Ferraiolo","raw_affiliation_strings":["Department of Pharmacological Sciences, Genentech, Inc. , South San Francisco, CA 94080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacological Sciences, Genentech, Inc. , South San Francisco, CA 94080","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037316439","display_name":"R Baughman","orcid":"https://orcid.org/0000-0003-2752-9855","observed_orcids":["https://orcid.org/0000-0003-2752-9855"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R A Baughman","raw_affiliation_strings":["Department of Pharmacological Sciences, Genentech, Inc. , South San Francisco, CA 94080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacological Sciences, Genentech, Inc. , South San Francisco, CA 94080","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113936933","display_name":"Albert B. DeLeo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A B Deleo","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center , New York, NY 10021"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center , New York, NY 10021","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029091770","display_name":"D Crase","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D Crase","raw_affiliation_strings":["Department of Pharmacological Sciences, Genentech, Inc. , South San Francisco, CA 94080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacological Sciences, Genentech, Inc. , South San Francisco, CA 94080","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009884500","display_name":"B J Marafino","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Marafino","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113822324","display_name":"Bharat B Aggarwal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B B Aggarwal","raw_affiliation_strings":["Department of Molecular Immunology, Genentech, Inc. , South San Francisco, CA 94080","Experimental Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Immunology, Genentech, Inc. , South San Francisco, CA 94080","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Experimental Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009407888","display_name":"I S Figari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"I S Figari","raw_affiliation_strings":["Department of Molecular Immunology, Genentech, Inc. , South San Francisco, CA 94080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Immunology, Genentech, Inc. , South San Francisco, CA 94080","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D Liggitt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D Liggitt","raw_affiliation_strings":["Department of Pharmacological Sciences, Genentech, Inc. , South San Francisco, CA 94080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacological Sciences, Genentech, Inc. , South San Francisco, CA 94080","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":null,"display_name":"J S Patton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J S Patton","raw_affiliation_strings":["Department of Pharmacological Sciences, Genentech, Inc. , South San Francisco, CA 94080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacological Sciences, Genentech, Inc. , South San Francisco, CA 94080","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":9.5125,"has_fulltext":false,"cited_by_count":200,"citation_normalized_percentile":{"value":0.98491739,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"138","issue":"11","first_page":"4023","last_page":"4032"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7666000127792358,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7666000127792358,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.04129999876022339,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.02449999935925007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9760000109672546},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.9190000295639038},{"id":"https://openalex.org/keywords/meth-a-sarcoma","display_name":"Meth A fibrosarcoma","score":0.9769999980926514},{"id":"https://openalex.org/keywords/tumor-specific-immunity","display_name":"tumor-specific immunity","score":0.7160000205039978},{"id":"https://openalex.org/keywords/tnf-alpha-receptor","display_name":"TNF-alpha receptor","score":0.8109999895095825},{"id":"https://openalex.org/keywords/tumor-necrosis","display_name":"tumor necrosis","score":0.878000020980835},{"id":"https://openalex.org/keywords/tumor-regression","display_name":"tumor regression","score":0.4399999976158142},{"id":"https://openalex.org/keywords/tumor-necrosis-factor-beta","display_name":"lymphotoxin","score":0.6489999890327454},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.9649999737739563},{"id":"https://openalex.org/keywords/interleukin-1","display_name":"interleukin-1","score":0.8489999771118164},{"id":"https://openalex.org/keywords/cytokines","display_name":"cytokines","score":0.6980000138282776},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.6629999876022339},{"id":"https://openalex.org/keywords/cytotoxic-antibodies","display_name":"cytotoxic antibodies","score":0.7120000123977661},{"id":"https://openalex.org/keywords/cell-mediated-immunity","display_name":"cell-mediated immunity","score":0.6600000262260437}],"concepts":[{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.7689538598060608},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.6425248980522156},{"id":"https://openalex.org/C503630168","wikidata":"https://www.wikidata.org/wiki/Q178069","display_name":"Necrosis","level":2,"score":0.6023094654083252},{"id":"https://openalex.org/C2780114369","wikidata":"https://www.wikidata.org/wiki/Q6823535","display_name":"Meth-","level":5,"score":0.5408045053482056},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5160767436027527},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.5105272531509399},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.4996514320373535},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.454612135887146},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.41412603855133057},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.41031017899513245},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4091631770133972},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3783496618270874},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34399890899658203},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3158324360847473},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.251054972410202},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23925510048866272},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06469589471817017},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.05500239133834839},{"id":"https://openalex.org/C166940927","wikidata":"https://www.wikidata.org/wiki/Q178827","display_name":"Monomer","level":3,"score":0.0},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.0},{"id":"https://openalex.org/C2779989194","wikidata":"https://www.wikidata.org/wiki/Q343016","display_name":"Acrylate","level":4,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003602","descriptor_name":"Cytotoxicity, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007109","descriptor_name":"Immunity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009336","descriptor_name":"Necrosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D012513","descriptor_name":"Sarcoma, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012513","descriptor_name":"Sarcoma, Experimental","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4049/jimmunol.138.11.4023","doi":"https://doi.org/10.4049/jimmunol.138.11.4023","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.138.11.4023","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},{"id":"pmid:3295044","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3295044","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of immunology (Baltimore, Md. : 1950)","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4988871824","display_name":"CELL SURFACE ANTIGENS OF SARCOMAS","funder_award_id":"R01CA028461","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2104345409","https://openalex.org/W2090064649","https://openalex.org/W2009036329","https://openalex.org/W786897919","https://openalex.org/W1916563986","https://openalex.org/W2014151228","https://openalex.org/W2060898697","https://openalex.org/W2428625291","https://openalex.org/W2129481772","https://openalex.org/W2143302220"],"abstract_inverted_index":{"We":[0],"have":[1],"investigated":[2],"the":[3,53,82,85,90,110,115,144,250,263,272,280,287],"in":[4,7,33,89,102,111,249,286,294],"vitro":[5,34,112],"and":[6,37,93,149,161,183,209],"vivo":[8],"antitumor":[9,54,176,292],"activities":[10],"of":[11,42,56,84,98,118,128,133,146,170,193,239,252,254,262,289],"recombinant":[12,155,162,178],"human":[13,156,179,184],"tumor":[14,151,157,164,265],"necrosis":[15,158,165,192,266],"factor-alpha":[16,166],"(rHuTNF-alpha)":[17],"against":[18,64],"Meth":[19,22,47,67,104,122,138,194,202,216,232,244,256],"A":[20,23,48,68,105,123,139,195,203,217,233,245,257],"sarcoma.":[21,69,196,234],"sarcoma":[24,49,124,204,218,246],"cells":[25],"were":[26,100,211,225,247],"found":[27,101,226],"to":[28,35,52,130,189,227,231,243],"a)":[29],"be":[30,228],"relatively":[31],"insensitive":[32,51],"rHuTNF-alpha,":[36],"b)":[38],"express":[39],"low":[40,96,116,237],"numbers":[41],"TNF-alpha":[43,119],"receptors.":[44],"Intraperitoneally":[45],"implanted":[46,66],"was":[50,61],"effects":[55],"rHuTNF-alpha.":[57],"In":[58,153,235],"contrast,":[59],"rHuTNF-alpha":[60,76,87,129,207,269],"highly":[62],"efficacious":[63],"subcutaneously":[65,214],"Biodistribution":[70],"studies":[71],"with":[72,143,174,215],"125I-":[73],"or":[74,219],"3H-labeled":[75],"demonstrated":[77],"that,":[78],"after":[79,206],"intravenous":[80],"administration,":[81],"majority":[83],"labeled":[86],"localized":[88],"kidney,":[91],"lungs,":[92],"liver.":[94],"Only":[95],"levels":[97,169,238],"radiolabel":[99],"subcutaneous":[103,137,201],"implants.":[106],"These":[107],"results":[108],"support":[109],"data":[113],"on":[114,121,279],"number":[117],"receptors":[120],"cells.":[125,282],"The":[126,283],"ability":[127],"induce":[131,190],"regression":[132],"established":[134],"(7":[135],"days)":[136],"implants,":[140],"positively":[141],"correlated":[142],"degree":[145],"both":[147],"macroscopic":[148],"microscopic":[150],"necrosis.":[152,171],"addition,":[154,236],"factor-beta":[159],"(lymphotoxin)":[160],"murine":[163,181],"induced":[167,223,267],"similar":[168],"Other":[172],"lymphokines":[173],"known":[175],"activities,":[177],"interferon-gamma,":[180,182],"interleukin":[185],"1":[186],"alpha,":[187],"failed":[188],"detectable":[191],"Mice":[197],"which":[198,210],"had":[199],"rejected":[200],"implants":[205],"treatment":[208],"later":[212],"challenged":[213],"other":[220],"noncross-reacting":[221],"chemically":[222],"sarcomas":[224],"specifically":[229],"immune":[230,258],"cytotoxic":[240],"antibodies":[241],"reactive":[242],"detected":[248],"sera":[251],"21":[253],"30":[255],"mice.":[259],"Histological":[260],"evaluation":[261],"hemorrhagic":[264],"by":[268],"suggests":[270],"that":[271],"primary":[273],"lesion":[274],"is":[275],"vascular,":[276],"possibly":[277],"directly":[278],"endothelial":[281],"mechanisms":[284],"involved":[285],"generation":[288],"specific":[290],"cell-mediated":[291],"immunity":[293],"this":[295],"model":[296],"are":[297],"at":[298],"present":[299],"unknown.":[300]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}